Acro Biomedical (ACBM) Asset Writedowns and Impairment (2023)
Acro Biomedical (ACBM) recorded quarterly Asset Writedowns and Impairment of $480000.0 in Q3 2023.
Acro Biomedical (ACBM) Asset Writedowns and Impairment (2023) Analysis & Trends
Acro Biomedical's Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $480000.0 for Q3 2023.
- In Q3 2023, Asset Writedowns and Impairment changed N/A year-over-year to $480000.0; the TTM figure through Dec 2024 stood at $480000.0 (changed N/A YoY), while the FY2023 annual figure was $480000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment was $480000.0 for Q3 2023 at Acro Biomedical.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $480000.0 in Q3 2023 to a low of $480000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 480,000.00 |
| Sep 30, 2023 | 480,000.00 |